2016-18922. Importer of Controlled Substances Registration

ACTION:

Notice of registration.

SUMMARY:

Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.

SUPPLEMENTARY INFORMATION:

The companies listed below applied to be registered as an importer of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted and no requests for hearing were submitted for these notices.

Company	FR Docket	Published
Mylan Pharmaceuticals, Inc.	80 FR 75691	December 3, 2015.
Hospira	81 FR 1208	January 11, 2016.
Cambrex Charles City	81 FR 14892	March 18, 2016.
Pharmacore	81 FR 15565	March 23, 2016.
Mallinckrodt LLC	81 FR 15566	March 23, 2016.
Meda Pharmaceuticals, Inc.	81 FR 15560	March 23, 2016.
Stepan Company	81 FR 20417	April 7, 2016

The DEA has considered the factors in 21 U.S.C. 823, 952(a) and 958(a) and determined that the registration of the listed registrants to import the applicable basic classes of schedule I or II controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the DEA has granted a registration as an importer for schedule I or II controlled substances to the above listed persons.

Dated: August 2, 2016.

Louis J. Milione,

Deputy Assistant Administrator.